New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Lumos Pharma Announces Clinical Updates
-
Lumos Pharma Announces Clinical Updates
-
Strive Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
-
HEP Announces Five Realizations and New Investment
-
CIT GAP Funds Makes Follow-On Investment in SCOUT to Continue Performing In-Space Inspections on Satellites
-
Mobile Payments Leader, Slide, Introduces Unique In-App Shopping Experience Providing 4-5% Cash Back
-
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
-
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
-
Form SC 13D CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
OmniSci Promotes Pey Silvester to Vice President of Engineering
-
Battery-less Solutions Flood In, Explores IDTechEx
-
Topia Talent Mobility Platform Now Available on the SAP® Store
-
Form SC 13D Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
-
Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe
-
Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe
-
Conviva Care Centers Expands Relationship with Strive Health to Provide Kidney Disease Care Management to Patients in Central and Northern Florida
-
Form 4 CVRx, Inc. For: Jul 02 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Vori Health Raises Additional Capital from Strategic Partners Intermountain Healthcare, Ascension Ventures, and Echo Health Ventures
-
Robinhood reveals breakneck growth, legal pitfalls in IPO filing
-
Form 4 Bright Health Group Inc. For: Jun 28 Filed by: New Enterprise Associates 15, L.P.
-
Everside Health Announces Four Appointments to Board of Directors
-
Form 3 CVRx, Inc. For: Jun 29 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
-
OmniSci Recognized by SIIA as Best Big Data Reporting & Analytics Solution
-
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
-
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
-
Form 3 Bright Health Group Inc. For: Jun 24 Filed by: New Enterprise Associates 15, L.P.
-
Form 3 Monte Rosa Therapeutics, For: Jun 23 Filed by: New Enterprise Associates 17, L.P.
-
Form SC 13D/A Desktop Metal, Inc. Filed by: New Enterprise Associates 15, L.P.
-
NEA Elevates Florence and Makhzoumi to Managing General Partner Roles, Promotes Several to Partner
-
Spiras Health Receives $14MM Series B Funding, Led by NEA
-
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
-
Broadly Announces Its Official Launch Into The Auto Collision Repair Sector
-
Health Tech Innovators Strive Health and Outset Medical Collaborate to Reinvent Kidney Care
-
CIT GAP Funds Invests in OxiWear to Support Innovations and Emergency Alerting for Pulmonary Hypertension
-
Topia's Technology Recognized by Relocate Awards and FEM America EMMAs as Positive Momentum Continues Into the Summer
-
Tessera Therapeutics Appoints Industry Leaders Elliott Sigal & Mary Rozenman to Board of Directors
-
Certara, Inc. (CERT) Appoints Dr. Carol Gallagher as New Independent Board Member
-
Certara Appoints Dr. Carol Gallagher as New Independent Board Member
-
Certara Appoints Dr. Carol Gallagher as New Independent Board Member
-
Health Enterprise Partners Completes Recapitalization of AllyAlign Health
-
Form 4 Desktop Metal, Inc. For: Jun 08 Filed by: New Enterprise Associates 15, L.P.
-
CIT GAP Funds Invests in Capango to Simplify Hiring Process for Restaurants and Retail
-
AllyAlign Health Partners with NEA to Accelerate Delivery of First-Class Care for Seniors
-
Pledge 1% Launches Boardroom Allies with Top Venture Capitalists to Unlock Billions in Corporate Philanthropy and Usher in a New Era of Social Impact
-
CIT GAP Funds Invests in Acomhal to Advance Therapies for Cancer Treatment
-
Form SC 13D/A Eargo, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Stablix Therapeutics Launches with $63 Million Series A Financing
-
Topia Awarded U.S. Patent on Exclusive Technology Powering Automated Compliance Management Solution

